Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration

202395 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT04126317.

Good health and well-being

Published in: JAMA Ophthalmology

Volume 141, Issue 9, pp. 834-834

Field-Weighted Citation Impact: 26.42